Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients

被引：13
|
作者：
Watson, Stuart [1 ]
Gallagher, Peter [1 ]
Smith, Margaret S. [1 ]
Young, Allan H. [1 ]
Ferrier, I. Nicol [1 ]
机构：
[1] Univ Newcastle Upon Tyne, Sch Neurol Neurobiol & Psychiat, Stanley Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
PSYCHONEUROENDOCRINOLOGY | 2007年 / 32卷 / 05期
关键词：
lithium; argipressin; bipolar disorder; major depressive disorder; hypothalamic-pituitary-adrenal axis; Dex/CRH test;
D O I：
10.1016/j.psyneuen.2007.02.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The impact of lithium on arginine vasopressin (AVP) release has implications for our understanding of the pathophysiology and treatment of mood disorders and for the interpretation of neuroendocrine studies. In this secondary analysis of neuroendocrine, data from 23 patients with chronic major depressive disorder, 41 patients with bipolar disorder and 18 healthy controls, we examine the relationship between lithium therapy, AVP levels and the cortisol response to the dexamethasone/corticotropin-releasing hormone (dex/CRH) test. These data demonstrate that patients taking lithium have elevated post-dexamethasone AVP levels compared to both healthy controls and patients not on lithium. (C) 2007 Elsevier Ltd. Alt rights reserved.
引用
收藏
页码：464 / 469
页数：6
相关论文
共 50 条
  • [41] Effect of CRH on the preovulatory LH and FSH surge in the cyclic rat: A role for arginine vasopressin?
    Roozendaal, MM
    Swarts, JJM
    Wolbers, WB
    Threels, A
    Wiegant, VM
    Mattheij, JAM
    JOURNAL OF NEUROENDOCRINOLOGY, 1996, 8 (10) : 765 - 770
  • [42] CORTICOTROPIN RELEASING HORMONE (CRH) AND ARGININE VASOPRESSIN (AVP) IN HYPOPHYSEAL PORTAL VESSEL BLOOD
    DOW, RC
    FINK, G
    ROBINSON, ICAF
    TANNAHILL, LA
    JOURNAL OF PHYSIOLOGY-LONDON, 1987, 382 : P42 - P42
  • [43] Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder
    de Kloet, Carien
    Vermetten, Eric
    Lentjes, Eef
    Geuze, Elbert
    van Pelt, Johannes
    Manuel, Remy
    Heijnen, Cobi
    Westenberg, Herman
    PSYCHONEUROENDOCRINOLOGY, 2008, 33 (03) : 313 - 320
  • [44] Stress hormone response to the DEX-CRH test and its relation to psychotherapy outcome in panic disorder patients with and without agoraphobia
    Wichmann, Susann
    Bornstein, Stefan R.
    Lorenz, Thomas
    Petrowski, Katja
    TRANSLATIONAL PSYCHIATRY, 2018, 8
  • [45] Delivery of services to mood disordered patients
    Simon, GE
    VonKorff, M
    CURRENT OPINION IN PSYCHIATRY, 1996, 9 (01) : 30 - 34
  • [46] The combined DEX-CRH test in treatment course and long-term outcome of major depression
    Hatzinger, M
    Hemmeter, UM
    Baumann, K
    Brand, S
    Holsboer-Trachsler, E
    JOURNAL OF PSYCHIATRIC RESEARCH, 2002, 36 (05) : 287 - 297
  • [47] Serotonin transporter polymorphism, gender and reported childhood maltreatment predict cortisol response to the Dex/CRH test
    Carpenter, Linda L.
    Ross, Nicole S.
    Gelernter, Joel
    Anderson, George
    Price, Lawrence H.
    Tyrka, Audrey R.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 93S - 93S
  • [48] PLASMA ARGININE VASOPRESSIN IN DEHYDRATED ELDERLY PATIENTS
    KIRKLAND, J
    LYE, M
    GODDARD, C
    VARGAS, E
    DAVIES, I
    CLINICAL ENDOCRINOLOGY, 1984, 20 (04) : 451 - 456
  • [49] Hyperresponsiveness of arginine vasopressin to metoclopramide in patients with pheochromocytoma
    Chiodera, P
    Volpi, R
    Coiro, V
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (21) : 2601 - 2603
  • [50] THE RELATIONSHIP BETWEEN PLASMA LITHIUM AND THE RENAL RESPONSIVENESS TO ARGININE VASOPRESSIN IN MAN
    PENNEY, MD
    HULLIN, RP
    SRINIVASAN, DP
    MORGAN, DB
    CLINICAL SCIENCE, 1981, 61 (06) : 793 - 795
12345